These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23649679)

  • 1. Resistant hypertension in the elderly: optimizing outcomes while avoiding adverse effects.
    Strunk AD; Mayer SD
    Consult Pharm; 2013 May; 28(5):307-12. PubMed ID: 23649679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication reconciliation: an important piece of the medication puzzle.
    Kennedy AK; Gatewood SB
    Consult Pharm; 2010 Dec; 25(12):829-33. PubMed ID: 21172763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of isolated systolic hypertension in older adults.
    Kamath N; Cappuzzo KA
    Consult Pharm; 2010 Jun; 25(6):374-8. PubMed ID: 20534408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
    Robinson JD; Segal R; Lopez LM; Doty RE
    Ann Pharmacother; 2010 Jan; 44(1):88-96. PubMed ID: 20040704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing Medication Adherence in Elderly Hypertensive Patients Through Pharmacist Home Visits.
    Moultry AM; Pounds K; Poon IO
    Consult Pharm; 2015 Dec; 30(12):710-9. PubMed ID: 26671271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.
    Sookaneknun P; Richards RM; Sanguansermsri J; Teerasut C
    Ann Pharmacother; 2004 Dec; 38(12):2023-8. PubMed ID: 15522983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pharmacist intervention on control of resistant hypertension.
    Morse GD; Douglas JB; Upton JH; Rodgers S; Gal P
    Am J Hosp Pharm; 1986 Apr; 43(4):905-9. PubMed ID: 3706334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients.
    St Peter WL; Farley TM; Carter BL
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):498-503. PubMed ID: 21709550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A substudy evaluating treatment intensification on medication adherence among hypertensive patients receiving home blood pressure telemonitoring and pharmacist management.
    Pawloski PA; Asche SE; Trower NK; Bergdall AR; Dehmer SP; Maciosek MV; Nyboer RA; O'Connor PJ; Sperl-Hillen JM; Green BB; Margolis KL
    J Clin Pharm Ther; 2016 Oct; 41(5):493-8. PubMed ID: 27363822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistant hypertension revisited: a comparison of two university-based cohorts.
    Garg JP; Elliott WJ; Folker A; Izhar M; Black HR;
    Am J Hypertens; 2005 May; 18(5 Pt 1):619-26. PubMed ID: 15882544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
    Von Muenster SJ; Carter BL; Weber CA; Ernst ME; Milchak JL; Steffensmeier JJ; Xu Y
    Pharm World Sci; 2008 Jan; 30(1):128-35. PubMed ID: 17710561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home blood pressure monitoring: a new standard method for monitoring hypertension control in treated patients.
    Pickering TG
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):762-3. PubMed ID: 18852711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical care and health outcomes in community settings: a matched pair analysis of perceptions of hypertensive patients versus pharmacists.
    Franic D; Pathak DS; Mott D
    Pharm Pract Manag Q; 1999 Jul; 19(2):1-17. PubMed ID: 10558091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical care program for patients with uncontrolled hypertension. Report of a double-blind clinical trial with ambulatory blood pressure monitoring.
    de Castro MS; Fuchs FD; Santos MC; Maximiliano P; Gus M; Moreira LB; Ferreira MB
    Am J Hypertens; 2006 May; 19(5):528-33. PubMed ID: 16647628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
    Epstein BJ
    Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing 'resistance': is adherence a target for treatment?
    Burnier M
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):439-43. PubMed ID: 25036746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist intervention program for control of hypertension.
    Chabot I; Moisan J; Grégoire JP; Milot A
    Ann Pharmacother; 2003 Sep; 37(9):1186-93. PubMed ID: 12921497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistant hypertension and the neglected antihypertensive: sodium restriction.
    Agarwal R
    Nephrol Dial Transplant; 2012 Nov; 27(11):4041-5. PubMed ID: 22899870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.